{"type": "FeatureCollection", "features": [{"id": "10.1016/j.peptides.2021.170696", "type": "Feature", "geometry": null, "properties": {"updated": "2026-10-06T16:16:31Z", "type": "Journal Article", "created": "2021-11-29", "title": "Immunomodulatory peptides\u2014A promising source for novel functional food production and drug discovery", "description": "Immunomodulatory peptides are a complex class of bioactive peptides that encompasses substances with different mechanisms of action. Immunomodulatory peptides could also be used in vaccines as adjuvants which would be extremely desirable, especially in response to pandemics. Thus, immunomodulatory peptides in food of plant origin could be regarded both as valuable suplements of novel functional food preparation and/or as precursors or possible active ingredients for drugs design for treatment variety of conditions arising from impaired function of immune system. Given variety of mechanisms, different tests are required to assess effects of immunomodulatory peptides. Some of those effects show good correlation with in vivo results but others, less so. Certain plant peptides, such as defensins, show both immunomodulatory and antimicrobial effect, which makes them interesting candidates for preparation of functional food and feed, as well as templates for design of synthetic peptides.", "keywords": ["0301 basic medicine", "2. Zero hunger", "Vaccines", "570", "0303 health sciences", "Immunomodulatory peptides  Defensin  Cryptic peptide  Functional food  Mechanism of action  Vaccines", "Functional food", "Cryptic peptide", "610", "Mechanism of action", "3. Good health", "Defensins", "Immunomodulation", "03 medical and health sciences", "Immunomodulatory peptide", "Defensin", "Functional Food", "Drug Discovery", "Humans", "Peptides", "Settore BIOS-10/A - Biologia cellulare e applicata", "Immunomodulatory peptides Defensin Cryptic peptide Functional food Mechanism of action Vaccines", "Plant Proteins"]}, "links": [{"href": "https://doi.org/10.1016/j.peptides.2021.170696"}, {"rel": "related", "href": "https://repository.soilwise-he.eu/cat/collections/metadata:main/items/Peptides", "name": "related record", "description": "related record", "type": "application/json"}, {"rel": "self", "type": "application/geo+json", "title": "10.1016/j.peptides.2021.170696", "name": "item", "description": "10.1016/j.peptides.2021.170696", "href": "https://repository.soilwise-he.eu/cat/collections/metadata:main/items/10.1016/j.peptides.2021.170696"}, {"rel": "collection", "type": "application/json", "title": "Collection", "name": "collection", "description": "Collection", "href": "https://repository.soilwise-he.eu/cat/collections/metadata:main"}], "time": {"date": "2022-02-01T00:00:00Z"}}, {"id": "10.1016/j.ijpddr.2024.100546", "type": "Feature", "geometry": null, "properties": {"updated": "2026-10-06T16:16:22Z", "type": "Journal Article", "created": "2024-05-05", "title": "Robenidine derivatives as potential antischistosomal drug candidates", "description": "Schistosomiasis caused by Schistosoma spp. is a disease that causes a considerable health burden to millions of people worldwide. The limited availability of effective drugs on the market and the increased risk of resistance development due to extensive usage, highlight the urgent need for new antischistosomal drugs. Recent studies have shown that robenidine derivatives, containing an aminoguanidine core, exhibit promising activities against Plasmodium falciparum, motivating further investigation into their efficacy against Schistosoma mansoni, due to their similar habitat and the resulting related cellular mechanisms like the heme detoxification pathway. The conducted phenotypic screening of robenidine and 80 derivatives against newly transformed schistosomula and adult Schistosoma mansoni yielded 11 candidates with low EC50 values for newly transformed schistosomula (1.12-4.63\u00a0\u03bcM) and adults (2.78-9.47\u00a0\u03bcM). The structure-activity relationship revealed that electron-withdrawing groups at the phenyl moiety, as well as the presence of methyl groups adjacent to the guanidine moiety, enhanced the activity of derivatives against both stages of Schistosoma mansoni. The two compounds 2,2'-Bis[(3-cyano-4-fluorophenyl)methylene] carbonimidic Dihydrazide Hydrochloride (1) and 2,2'-Bis[(4-difluoromethoxyphenyl) ethylidene] carbonimidic Dihydrazide Hydrochloride (19), were selected for an in vivo study in Schistosoma mansoni-infected mice based on their potency, cytotoxicity, pharmacokinetic-, and physicochemical properties, but failed to reduce the worm burden significantly (worm burden reduction <20%). Thus, robenidine derivatives require further refinements to obtain higher antischistosomal specificity and in vivo activity.", "keywords": ["Male", "0301 basic medicine", "0303 health sciences", "Drug discovery", "Infectious and parasitic diseases", "RC109-216", "Schistosoma mansoni", "Structure-activity relationship", "Guanidines", "Article", "Schistosomiasis mansoni", "3. Good health", "Mice", "Schistosomicides", "Structure-Activity Relationship", "03 medical and health sciences", "Aminoguanidine", "Animals", "Female", "Robenidine derivative"], "contacts": [{"organization": "Christian N. Lotz, Alina Krollenbrock, Lea Imhof, Michael Riscoe, Jennifer Keiser,", "roles": ["creator"]}]}, "links": [{"href": "https://doi.org/10.1016/j.ijpddr.2024.100546"}, {"rel": "related", "href": "https://repository.soilwise-he.eu/cat/collections/metadata:main/items/International%20Journal%20for%20Parasitology%3A%20Drugs%20and%20Drug%20Resistance", "name": "related record", "description": "related record", "type": "application/json"}, {"rel": "self", "type": "application/geo+json", "title": "10.1016/j.ijpddr.2024.100546", "name": "item", "description": "10.1016/j.ijpddr.2024.100546", "href": "https://repository.soilwise-he.eu/cat/collections/metadata:main/items/10.1016/j.ijpddr.2024.100546"}, {"rel": "collection", "type": "application/json", "title": "Collection", "name": "collection", "description": "Collection", "href": "https://repository.soilwise-he.eu/cat/collections/metadata:main"}], "time": {"date": "2024-08-01T00:00:00Z"}}, {"id": "10.1039/d4np00045e", "type": "Feature", "geometry": null, "properties": {"updated": "2026-10-06T16:17:24Z", "type": "Journal Article", "created": "2025-02-25", "title": "Antarctic bacterial natural products: from genomic insights to drug discovery", "description": "<?xml version='1.0' encoding='UTF-8'?><article><p>The article highlights the available data on Antarctic bacteria, their biosynthetic potential, and the successful NP discoveries while addressing the challenges in NP research and advocating for systematic, collaborative research in Antarctica.</p></article>", "keywords": ["Biological Products", "Bacteria", "Molecular Structure", "Drug Discovery", "Antarctic Regions", "Genomics"]}, "links": [{"href": "http://pubs.rsc.org/en/content/articlepdf/2025/NP/D4NP00045E"}, {"href": "https://doi.org/10.1039/d4np00045e"}, {"rel": "related", "href": "https://repository.soilwise-he.eu/cat/collections/metadata:main/items/Natural%20Product%20Reports", "name": "related record", "description": "related record", "type": "application/json"}, {"rel": "self", "type": "application/geo+json", "title": "10.1039/d4np00045e", "name": "item", "description": "10.1039/d4np00045e", "href": "https://repository.soilwise-he.eu/cat/collections/metadata:main/items/10.1039/d4np00045e"}, {"rel": "collection", "type": "application/json", "title": "Collection", "name": "collection", "description": "Collection", "href": "https://repository.soilwise-he.eu/cat/collections/metadata:main"}], "time": {"date": "2025-01-01T00:00:00Z"}}, {"id": "10.3390/ijms24076573", "type": "Feature", "geometry": null, "properties": {"updated": "2026-10-06T16:19:39Z", "type": "Journal Article", "created": "2023-04-03", "title": "A Systematic Review of Deep Learning Methodologies Used in the Drug Discovery Process with Emphasis on In Vivo Validation", "description": "<?xml version='1.0' encoding='UTF-8'?><article><p>The discovery and development of new drugs are extremely long and costly processes. Recent progress in artificial intelligence has made a positive impact on the drug development pipeline. Numerous challenges have been addressed with the growing exploitation of drug-related data and the advancement of deep learning technology. Several model frameworks have been proposed to enhance the performance of deep learning algorithms in molecular design. However, only a few have had an immediate impact on drug development since computational results may not be confirmed experimentally. This systematic review aims to summarize the different deep learning architectures used in the drug discovery process and are validated with further in vivo experiments. For each presented study, the proposed molecule or peptide that has been generated or identified by the deep learning model has been biologically evaluated in animal models. These state-of-the-art studies highlight that even if artificial intelligence in drug discovery is still in its infancy, it has great potential to accelerate the drug discovery cycle, reduce the required costs, and contribute to the integration of the 3R (Replacement, Reduction, Refinement) principles. Out of all the reviewed scientific articles, seven algorithms were identified: recurrent neural networks, specifically, long short-term memory (LSTM-RNNs), Autoencoders (AEs) and their Wasserstein Autoencoders (WAEs) and Variational Autoencoders (VAEs) variants; Convolutional Neural Networks (CNNs); Direct Message Passing Neural Networks (D-MPNNs); and Multitask Deep Neural Networks (MTDNNs). LSTM-RNNs were the most used architectures with molecules or peptide sequences as inputs.</p></article>", "keywords": ["Deep Learning", "Artificial Intelligence", "Drug Discovery", "Review", "Neural Networks", " Computer", "drug discovery; drug design; artificial intelligence; machine learning; deep learning; biological evaluation; animal model; in vivo", "Algorithms", "3. Good health"]}, "links": [{"href": "https://www.mdpi.com/1422-0067/24/7/6573/pdf"}, {"href": "https://doi.org/10.3390/ijms24076573"}, {"rel": "related", "href": "https://repository.soilwise-he.eu/cat/collections/metadata:main/items/International%20Journal%20of%20Molecular%20Sciences", "name": "related record", "description": "related record", "type": "application/json"}, {"rel": "self", "type": "application/geo+json", "title": "10.3390/ijms24076573", "name": "item", "description": "10.3390/ijms24076573", "href": "https://repository.soilwise-he.eu/cat/collections/metadata:main/items/10.3390/ijms24076573"}, {"rel": "collection", "type": "application/json", "title": "Collection", "name": "collection", "description": "Collection", "href": "https://repository.soilwise-he.eu/cat/collections/metadata:main"}], "time": {"date": "2023-03-31T00:00:00Z"}}, {"id": "11381/2905288", "type": "Feature", "geometry": null, "properties": {"updated": "2026-10-06T16:22:31Z", "type": "Journal Article", "created": "2021-11-29", "title": "Immunomodulatory peptides\u2014A promising source for novel functional food production and drug discovery", "description": "Immunomodulatory peptides are a complex class of bioactive peptides that encompasses substances with different mechanisms of action. Immunomodulatory peptides could also be used in vaccines as adjuvants which would be extremely desirable, especially in response to pandemics. Thus, immunomodulatory peptides in food of plant origin could be regarded both as valuable suplements of novel functional food preparation and/or as precursors or possible active ingredients for drugs design for treatment variety of conditions arising from impaired function of immune system. Given variety of mechanisms, different tests are required to assess effects of immunomodulatory peptides. Some of those effects show good correlation with in vivo results but others, less so. Certain plant peptides, such as defensins, show both immunomodulatory and antimicrobial effect, which makes them interesting candidates for preparation of functional food and feed, as well as templates for design of synthetic peptides.", "keywords": ["0301 basic medicine", "2. Zero hunger", "Vaccines", "570", "0303 health sciences", "Functional food", "Cryptic peptide", "610", "Mechanism of action", "3. Good health", "Defensins", "Immunomodulation", "03 medical and health sciences", "Immunomodulatory peptide", "Defensin", "Functional Food", "Drug Discovery", "Humans", "Peptides", "Settore BIOS-10/A - Biologia cellulare e applicata", "Plant Proteins"]}, "links": [{"href": "https://doi.org/11381/2905288"}, {"rel": "related", "href": "https://repository.soilwise-he.eu/cat/collections/metadata:main/items/Peptides", "name": "related record", "description": "related record", "type": "application/json"}, {"rel": "self", "type": "application/geo+json", "title": "11381/2905288", "name": "item", "description": "11381/2905288", "href": "https://repository.soilwise-he.eu/cat/collections/metadata:main/items/11381/2905288"}, {"rel": "collection", "type": "application/json", "title": "Collection", "name": "collection", "description": "Collection", "href": "https://repository.soilwise-he.eu/cat/collections/metadata:main"}], "time": {"date": "2022-02-01T00:00:00Z"}}, {"id": "20864344", "type": "Feature", "geometry": null, "properties": {"updated": "2026-10-06T16:22:55Z", "type": "Journal Article", "created": "2010-09-08", "title": "Discovery and optimization of adamantyl carbamate inhibitors of 11\u03b2-HSD1", "description": "Synthesis of 2-adamantyl carbamate derivatives of piperidines and pyrrolidines led to the discovery of 9a with an IC(50) of 15.2 nM against human 11\u03b2-HSD1 in adipocytes. Optimization for increased adipocyte potency, metabolic stability and selectivity afforded 11k and 11l, both of which were >25% orally bioavailable in rat.", "keywords": ["Models", " Molecular", "0301 basic medicine", "0303 health sciences", "03 medical and health sciences", "11-beta-Hydroxysteroid Dehydrogenase Type 1", "Drug Discovery", "Animals", "Adamantane", "Enzyme Inhibitors", "Rats", "3. Good health"]}, "links": [{"href": "https://doi.org/20864344"}, {"rel": "related", "href": "https://repository.soilwise-he.eu/cat/collections/metadata:main/items/Bioorganic%20%26amp%3B%20Medicinal%20Chemistry%20Letters", "name": "related record", "description": "related record", "type": "application/json"}, {"rel": "self", "type": "application/geo+json", "title": "20864344", "name": "item", "description": "20864344", "href": "https://repository.soilwise-he.eu/cat/collections/metadata:main/items/20864344"}, {"rel": "collection", "type": "application/json", "title": "Collection", "name": "collection", "description": "Collection", "href": "https://repository.soilwise-he.eu/cat/collections/metadata:main"}], "time": {"date": "2010-11-01T00:00:00Z"}}, {"id": "PMC11101930", "type": "Feature", "geometry": null, "properties": {"updated": "2026-10-06T16:24:58Z", "type": "Journal Article", "created": "2024-05-05", "title": "Robenidine derivatives as potential antischistosomal drug candidates", "description": "Schistosomiasis caused by Schistosoma spp. is a disease that causes a considerable health burden to millions of people worldwide. The limited availability of effective drugs on the market and the increased risk of resistance development due to extensive usage, highlight the urgent need for new antischistosomal drugs. Recent studies have shown that robenidine derivatives, containing an aminoguanidine core, exhibit promising activities against Plasmodium falciparum, motivating further investigation into their efficacy against Schistosoma mansoni, due to their similar habitat and the resulting related cellular mechanisms like the heme detoxification pathway. The conducted phenotypic screening of robenidine and 80 derivatives against newly transformed schistosomula and adult Schistosoma mansoni yielded 11 candidates with low EC50 values for newly transformed schistosomula (1.12-4.63\u00a0\u03bcM) and adults (2.78-9.47\u00a0\u03bcM). The structure-activity relationship revealed that electron-withdrawing groups at the phenyl moiety, as well as the presence of methyl groups adjacent to the guanidine moiety, enhanced the activity of derivatives against both stages of Schistosoma mansoni. The two compounds 2,2'-Bis[(3-cyano-4-fluorophenyl)methylene] carbonimidic Dihydrazide Hydrochloride (1) and 2,2'-Bis[(4-difluoromethoxyphenyl) ethylidene] carbonimidic Dihydrazide Hydrochloride (19), were selected for an in vivo study in Schistosoma mansoni-infected mice based on their potency, cytotoxicity, pharmacokinetic-, and physicochemical properties, but failed to reduce the worm burden significantly (worm burden reduction <20%). Thus, robenidine derivatives require further refinements to obtain higher antischistosomal specificity and in vivo activity.", "keywords": ["Male", "0301 basic medicine", "0303 health sciences", "Drug discovery", "Infectious and parasitic diseases", "RC109-216", "Schistosoma mansoni", "Structure-activity relationship", "Guanidines", "Article", "Schistosomiasis mansoni", "3. Good health", "Mice", "Schistosomicides", "Structure-Activity Relationship", "03 medical and health sciences", "Aminoguanidine", "Animals", "Female", "Robenidine derivative"], "contacts": [{"organization": "Christian N. Lotz, Alina Krollenbrock, Lea Imhof, Michael Riscoe, Jennifer Keiser,", "roles": ["creator"]}]}, "links": [{"href": "https://doi.org/PMC11101930"}, {"rel": "related", "href": "https://repository.soilwise-he.eu/cat/collections/metadata:main/items/International%20Journal%20for%20Parasitology%3A%20Drugs%20and%20Drug%20Resistance", "name": "related record", "description": "related record", "type": "application/json"}, {"rel": "self", "type": "application/geo+json", "title": "PMC11101930", "name": "item", "description": "PMC11101930", "href": "https://repository.soilwise-he.eu/cat/collections/metadata:main/items/PMC11101930"}, {"rel": "collection", "type": "application/json", "title": "Collection", "name": "collection", "description": "Collection", "href": "https://repository.soilwise-he.eu/cat/collections/metadata:main"}], "time": {"date": "2024-08-01T00:00:00Z"}}, {"id": "PMC10095548", "type": "Feature", "geometry": null, "properties": {"updated": "2026-10-06T16:24:56Z", "type": "Journal Article", "created": "2023-04-03", "title": "A Systematic Review of Deep Learning Methodologies Used in the Drug Discovery Process with Emphasis on In Vivo Validation", "description": "<?xml version='1.0' encoding='UTF-8'?><article><p>The discovery and development of new drugs are extremely long and costly processes. Recent progress in artificial intelligence has made a positive impact on the drug development pipeline. Numerous challenges have been addressed with the growing exploitation of drug-related data and the advancement of deep learning technology. Several model frameworks have been proposed to enhance the performance of deep learning algorithms in molecular design. However, only a few have had an immediate impact on drug development since computational results may not be confirmed experimentally. This systematic review aims to summarize the different deep learning architectures used in the drug discovery process and are validated with further in vivo experiments. For each presented study, the proposed molecule or peptide that has been generated or identified by the deep learning model has been biologically evaluated in animal models. These state-of-the-art studies highlight that even if artificial intelligence in drug discovery is still in its infancy, it has great potential to accelerate the drug discovery cycle, reduce the required costs, and contribute to the integration of the 3R (Replacement, Reduction, Refinement) principles. Out of all the reviewed scientific articles, seven algorithms were identified: recurrent neural networks, specifically, long short-term memory (LSTM-RNNs), Autoencoders (AEs) and their Wasserstein Autoencoders (WAEs) and Variational Autoencoders (VAEs) variants; Convolutional Neural Networks (CNNs); Direct Message Passing Neural Networks (D-MPNNs); and Multitask Deep Neural Networks (MTDNNs). LSTM-RNNs were the most used architectures with molecules or peptide sequences as inputs.</p></article>", "keywords": ["Deep Learning", "Artificial Intelligence", "Drug Discovery", "Review", "Neural Networks", " Computer", "Algorithms", "3. Good health"]}, "links": [{"href": "https://www.mdpi.com/1422-0067/24/7/6573/pdf"}, {"href": "https://doi.org/PMC10095548"}, {"rel": "related", "href": "https://repository.soilwise-he.eu/cat/collections/metadata:main/items/International%20Journal%20of%20Molecular%20Sciences", "name": "related record", "description": "related record", "type": "application/json"}, {"rel": "self", "type": "application/geo+json", "title": "PMC10095548", "name": "item", "description": "PMC10095548", "href": "https://repository.soilwise-he.eu/cat/collections/metadata:main/items/PMC10095548"}, {"rel": "collection", "type": "application/json", "title": "Collection", "name": "collection", "description": "Collection", "href": "https://repository.soilwise-he.eu/cat/collections/metadata:main"}], "time": {"date": "2023-03-31T00:00:00Z"}}], "links": [{"rel": "self", "type": "application/geo+json", "title": "This document as GeoJSON", "href": "https://repository.soilwise-he.eu/cat/collections/metadata:main/items?keywords=Drug+Discovery&f=json", "hreflang": "en-US"}, {"rel": "alternate", "type": "text/html", "title": "This document as HTML", "href": "https://repository.soilwise-he.eu/cat/collections/metadata:main/items?keywords=Drug+Discovery&f=html", "hreflang": "en-US"}, {"rel": "collection", "type": "application/json", "title": "Collection URL", "href": "https://repository.soilwise-he.eu/cat/collections/metadata:main", "hreflang": "en-US"}, {"type": "application/geo+json", "rel": "first", "title": "items (first)", "href": "https://repository.soilwise-he.eu/cat/collections/metadata:main/items?keywords=Drug+Discovery&", "hreflang": "en-US"}, {"rel": "last", "type": "application/geo+json", "title": "items (last)", "href": "https://repository.soilwise-he.eu/cat/collections/metadata:main/items?keywords=Drug+Discovery&offset=8", "hreflang": "en-US"}], "numberMatched": 8, "numberReturned": 8, "distributedFeatures": [], "timeStamp": "2026-11-22T14:06:36.332651Z"}